Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Carbohydrates, glycemic index and diabetes mellitus

Sucralose enhances GLP-1 release and lowers blood glucose in the presence of carbohydrate in healthy subjects but not in patients with type 2 diabetes

European Journal of Clinical Nutrition volume 69, pages 162–166 (2015)Cite this article

Subjects

Abstract

Background/objective:

Artificial sweeteners were thought to be metabolically inactive, but after demonstrating that the gustatory mechanism was also localized in the small intestine, suspicions about the metabolic effects of artificial sweeteners have emerged. The objective of this study was to determine the effect of artificial sweeteners (aspartame and sucralose) on blood glucose, insulin, c-peptide and glucagon-like peptide-1 (GLP-1) levels.

Subjects/methods:

Eight newly diagnosed drug-naive type 2 diabetic patients (mean age 51.5±9.2 years; F/M: 4/4) and eight healthy subjects (mean age 45.0±4.1 years; F/M: 4/4) underwent 75 g oral glucose tolerance test (OGTT). During OGTT, glucose, insulin, c-peptide and GLP-1 were measured at 15- min intervals for 120 min. The OGTTs were performed at three settings on different days, where subjects were given 72 mg of aspartame and 24 mg of sucralose in 200 ml of water or 200 ml of water alone 15 min before OGTT in a single-blinded randomized order.

Results:

In healthy subjects, the total area under the curve (AUC) of glucose was statistically significantly lower in the sucralose setting than in the water setting (P=0.002). There was no difference between the aspartame setting and the water setting (P=0.53). Total AUC of insulin and c-peptide was similar in aspartame, sucralose and water settings. Total AUC of GLP-1 was significantly higher in the sucralose setting than in the water setting (P=0.04). Total AUC values of glucose, insulin, c-peptide and GLP-1 were not statistically different in three settings in type 2 diabetic patients.

Conclusions:

Sucralose enhances GLP-1 release and lowers blood glucose in the presence of carbohydrate in healthy subjects but not in newly diagnosed type 2 diabetic patients.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Höfer D, Asan E, Drenckhahn D . Chemosensory perception in the gut. News Physiol Sci 1999; 14: 18–23.

    PubMed  Google Scholar 

  2. Höfer D, Püschel B, Drenckhahn D . Taste receptor-like cells in the rat gut identified by expression of alpha-gustducin. Proc Natl Acad Sci USA 1996; 93: 6631–6634.

    Article  Google Scholar 

  3. Jang HJ, Kokrashvili Z, Theodorakis MJ, Carlson OD, Kim BJ, Zhou J et al. Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1. Proc Natl Acad Sci USA 2007; 104: 15069–15074.

    Article  CAS  Google Scholar 

  4. Kokrashvili Z, Mosinger B, Margolskee RF . Taste signaling elements expressed in gut enteroendocrine cells regulate nutrient-responsive secretion of gut hormones. Am J Clin Nutr 2009; 90: 822S–825S.

    Article  CAS  Google Scholar 

  5. Margolskee RF, Dyer J, Kokrashvili Z, Salmon KS, Ilegems E, Daly K et al. T1R3 and gustducin in gut sense sugars to regulate expression of Na+-glucose cotransporter 1. Proc Natl Acad Sci USA 2007; 104: 15075–15080.

    Article  CAS  Google Scholar 

  6. Hellen M . Sweeteners and Sugar Alternatives in Food Tecnology, 1st edn. Blackwell Publishing Ltd: Garsington Road, Oxford, UK, 2006, pp 146–148.

    Google Scholar 

  7. Brown RJ, Walter M, Rother KI . Effects of diet soda on gut hormones in youths with diabetes. Diabetes Care 2012; 35: 959–964.

    Article  CAS  Google Scholar 

  8. Reimann F, Habib AM, Tolhurst G, Parker HE, Rogers GJ, Gribble FM . Glucose sensing in L cells: a primary cell study. Cell Metab 2008; 8: 532–539.

    Article  CAS  Google Scholar 

  9. Steinert RE, Frey F, Töpfer A, Drewe J, Beglinger C . Effects of carbohydrate sugars and artificial sweeteners on appetite and the secretion of gastrointestinal satiety peptides. Br J Nutr 2011; 105: 1320–1328.

    Article  CAS  Google Scholar 

  10. Ma J, Chang J, Checklin HL, Young RL, Jones KL, Horowitz M et al. Effect of the artificial sweetener, sucralose, on small intestinal glucose absorption in healthy human subjects. Br J Nutr 2010; 104: 803–806.

    Article  CAS  Google Scholar 

  11. Ma J, Bellon M, Wishart JM, Young R, Blackshaw LA, Jones KL et al. Effect of the artificial sweetener, sucralose, on gastric emptying and incretin hormone release in healthy subjects. Am J Physiol Gastrointest Liver Physiol 2009; 296: G735–G739.

    Article  CAS  Google Scholar 

  12. Gregersen S, Jeppesen PB, Holst JJ, Hermansen K . Antihyperglycemic effects of stevioside in type 2 diabetic subjects. Metabolism 2004; 53: 73–76.

    Article  CAS  Google Scholar 

  13. Mezitis NH, Maggio CA, Koch P, Quddoos A, Allison DB, Pi-Sunyer FX . Glycemic effect of a single high oral dose of the novel sweetener sucralose in patients with diabetes. Diabetes Care 1996; 19: 1004–1005.

    Article  CAS  Google Scholar 

  14. Wu T, Bound MJ, Standfield SD, Bellon M, Young RL, Jones KL et al. Artificial sweeteners have no effect on gastrc emtying, glucagon-like peptide-1, or glycemia after oral glucose in healthy humans. Diabetes Care 2013; 36: e202–e203.

    Article  Google Scholar 

  15. Grotz VL, Henry RR, McGill JB, Prince MJ, Shamoon H, Trout JR et al. Lack of effect of sucralose on glucose homeostasis in subjects with type 2 diabetes. J Am Diet Assoc 2003; 103: 1607–1612.

    Article  Google Scholar 

  16. Barriocanal LA, Palacios M, Benitez G, Benitez S, Jimenez JT, Jimenez N et al. Apparent lack of pharmacological effect of steviol glycosides used as sweeteners in humans. A pilot study of repeated exposures in some normotensive and ypotensive individuals and in type 1 and type 2 diabetics. Regul Toxicol Pharmacol 2008; 51: 37–41.

    Article  CAS  Google Scholar 

  17. Maki KC, Curry LL, Reeves MS, Toth PD, McKenney JM, Farmer MV et al. Chronic consumption of rebaudioside A, a steviol glycoside, in men and women with type 2 diabetes mellitus. Food Chem Toxicol 2008; 46 (Suppl 7): S47–S53.

    Article  CAS  Google Scholar 

  18. Cooper PL, Wahlqvist ML, Simpson RW . Sucrose versus saccharin as an added sweetener in non-insulin-dependent diabetes: short- and medium-term metabolic effects. Diabet Med 1988; 5: 676–680.

    Article  CAS  Google Scholar 

  19. Pepino MY, Tiemann CD, Patterson BW, Wice BM, Klein S . Sucralose affects glycemic and hormonal responses to an oral glucose load. Diabetes Care 2013; 36: 2530–2535.

    Article  CAS  Google Scholar 

  20. Mace OJ, Affleck J, Patel N, Kellett GL . Sweet taste receptors in rat small intestine stimulate glucose absorption through apical GLUT2. J Physiol 2007; 582 (Part 1): 379–392.

    Article  CAS  Google Scholar 

  21. Gouyon F, Caillaud L, Carriere V, Klein C, Dalet V, Citadelle D et al. Simple-sugar meals target GLUT2 at enterocyte apical membranes to improve sugar absorption: a study in GLUT2-null mice. J Physiol 2003; 552 (Part 3): 823–832.

    Article  CAS  Google Scholar 

  22. Dyer J, Vayro S, King TP, Shirazi-Beechey SP . Glucose sensing in the intestinal epithelium. Eur J Biochem 2003; 270: 3377–3388.

    Article  CAS  Google Scholar 

  23. Prigeon RL, Quddusi S, Paty B, D'Alessio DA . Suppression of glucose production by GLP-1 independent of islet hormones: a novel extrapancreatic effect. Am J Physiol Endocrinol Metab 2003; 285: E701–E707.

    Article  CAS  Google Scholar 

  24. Vollmer K, Holst JJ, Baller B, Ellrichmann M, Nauck MA, Schmidt WE et al. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance. Diabetes 2008; 57: 678–687.

    Article  CAS  Google Scholar 

  25. Young RL, Sutherland K, Pezos N, Brierley SM, Horowitz M, Rayner CK et al. Expression of taste molecules in the upper gastrointestinal tract in humans with and without type 2 diabetes. Gut 2009; 58: 337–346.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology and Metabolic Diseases, Marmara University Faculty of Medicine, Istanbul, Turkey,

    S Temizkan, O Deyneli, M Yasar, M Gunes, D Yazici & D G Yavuz

  2. Department of Biochemistry, Marmara University Faculty of Medicine, Istanbul, Turkey,

    M Arpa, O Sirikci & G Haklar

  3. Department of Gastroenterology, Marmara University Faculty of Medicine, Istanbul, Turkey

    N Imeryuz

Authors
  1. S Temizkan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. O Deyneli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M Yasar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M Arpa
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M Gunes
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. D Yazici
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. O Sirikci
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. G Haklar
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. N Imeryuz
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. D G Yavuz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S Temizkan.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Temizkan, S., Deyneli, O., Yasar, M. et al. Sucralose enhances GLP-1 release and lowers blood glucose in the presence of carbohydrate in healthy subjects but not in patients with type 2 diabetes. Eur J Clin Nutr 69, 162–166 (2015). https://doi.org/10.1038/ejcn.2014.208

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ejcn.2014.208

This article is cited by

Search

Advanced search

Quick links